Siliconized vials make every drop count!

Siliconized vials of Nipro PharmaPackaging India provide lower drug residual volumes compared to non-siliconized vials.

Recently, an in-house study¹ was conducted using a test method recognized in the industry. The results show a very significant impact on the drug residual volume of siliconized vials compared to non-siliconized vials. The additional silicone layer, with its hydrophobic properties, prevents high viscosity drugs from sticking to the internal glass surface which leads to less drug residuals. Thus, the test solution left over in siliconized vials is considerably less than in non-siliconized vials.

Vials with a lower drug residual volume offer a substantial benefit. Depending on the degree of reduction, pharmaceutical companies will be able to reduce the overfill of vials. In addition to cost reduction, this also allows an additional number of vials to be filled with the valuable medication that is saved, making each drop count.

“We are proud to manufacture siliconized vials that contribute to saving valuable drug products, and make every drop count!”

Ashish Moghe Managing Director, Nipro PharmaPackaging India

Nipro PharmaPackaging India manufactures 2R to 30R siliconized vials at the state-of-the-art plant near Pune. The site complies to ISO 15378, ISO 9001, ISO 14001, and ISO 45001. Each vial is subjected to stringent cosmetic and dimensional quality inspections during the converting, siliconization, and packing processes. The siliconization and packing are realized in an ISO 8 cleanroom environment. Additional in-process controls (IPCs) and a very strict final inspection ensure that the vials meet the agreed quality requirements of our business partners.